The findings confirm that allosteric inhibition of integrase is clinically viable, validating a new antiviral drug class.

The Trump administration’s new global HIV prevention strategy prioritizes preventing mother-to-child HIV transmission. About ...

Some lawmakers and advocates are increasingly uncertain whether critical HIV and AIDS services will survive the federal government’s funding fight. The GOP’s House-passed budget bill seeks to cut ...

Protecting public health abroad benefits Americans. In a globalized world, diseases and their social and economic impacts do ...

APPLIN: After nearly 20 years in HIV care, I’ve seen that HIV follows people through every season of life. When life is stable, patients stay in care and maintain suppression, but when challenges ...

Gilead is actively looking for late-stage and de-risked assets for potential deals across various therapeutic spaces, ...

Cabotegravir was already approved for use in England and Wales as part of a combination treatment for people living with HIV. Now, the drug will be available to those who are HIV-negative and looking ...

The Institute of Human Virology Nigeria reports significant progress in Rivers State’s Prevention of Mother-to-Child ...

South Africa has become the first African country — and our medicines regulator the third worldwide — to register the revolutionary twice-a-year anti-HIV jab, lenacapavir (LEN), that could bring an ...

South Africa has become the first African country, and our medicines regulator the third worldwide, to register the revolutionary twice-a-year anti-HIV jab lenacapavir that could bring an end to ...

Len is for HIV-negative people to try and stop them from getting HIV…when you get an injection, the contents of the injection release slowly in your body over a period of six months,’ says Mia Malan ...